Kimberly-Clark Acquisition of Safeskin Completed
Safeskin Shareholders Approve Transaction
DALLAS, TX-The acquisition agreement signed in November 1999 between Kimberly-Clark Corporation and Safeskin Corporation has been approved by Safeskin shareholders. By approving the merger, Safeskin shareholders gave Kimberly-Clark entrance to the latex and synthetic glove market. Chairman and chief executive officer of Kimberly-Clark, Wayne R. Sanders, commented, "Safeskin has built one of the fastest growing, most technologically innovative and cost-effective businesses in the glove industry. We are pleased to complement our expanding offering of professional healthcare products with Safeskin gloves. With this acquisition, we will be able to offer a complete line of head-to-toe protection products for healthcare workers."
Valued at $800 million, the transaction includes issuing Safeskin shareholders .1956 of a share of Kimberly-Clark common stock for each share of Safeskin common stock. David R. Murray, president of Kimberly-Clark's professional healthcare sector will assume leadership of the Safeskin line and Richard Jaffe, chairman, president and chief executive officer of Safeskin will become a company consultant.
Gag Order Puts Public Health at Risk, APIC Urges Immediate Action
February 4th 2025APIC warns that the HHS gag order on CDC communications endangers public health, delaying critical infection updates and weakening outbreak response amid rising tuberculosis, avian flu, Ebola, and measles threats.
Breaking Barriers: The Future of HIV Prevention and the Fight for Widespread PrEP Access
January 31st 2025Despite medical advances, HIV prevention faces roadblocks—low PrEP adoption, stigma, and accessibility issues threaten progress. Experts push for innovative, long-acting solutions to end the epidemic.
The Hidden Dangers of Hospital Ventilation: Are We Spreading Viruses Further?
January 31st 2025New research reveals hospital ventilation and air purifiers may unintentionally spread viral particles, increasing infection risks. Infection preventionists must rethink airflow strategies to protect patients and staff.
